Zoledronic Acid for Injection

Zoledronic Acid for Injection

Categories : Oncology

Product Packaging : 5 ml Glass Vial

Product Composition : 4 mg

Zoledronic Acid for Injection is a potent bisphosphonate medication used to treat bone-related complications associated with cancer and metabolic bone disorders. It works by inhibiting osteoclast-mediated bone resorption, thereby strengthening bones and reducing the risk of fractures.

This injectable formulation is widely used in the management of bone metastases, hypercalcemia of malignancy, and osteoporosis, making it an essential therapy in both oncology and supportive care.

Genliva Wellness LLP is a leading Zoledronic Acid Injection exporter from India, supplying high-quality sterile injectables to international pharmaceutical markets across Africa, Asia, CIS, and Middle East regions. As a reliable global supplier of bisphosphonate injections, the company supports hospitals, distributors, and tender-based procurement worldwide.

Send Message

Zoledronic Acid for Injection is a potent bisphosphonate medication used to treat bone-related complications associated with cancer and metabolic bone disorders. It works by inhibiting osteoclast-mediated bone resorption, thereby strengthening bones and reducing the risk of fractures.

This injectable formulation is widely used in the management of bone metastases, hypercalcemia of malignancy, and osteoporosis, making it an essential therapy in both oncology and supportive care.

Genliva Wellness LLP is a leading Zoledronic Acid Injection exporter from India, supplying high-quality sterile injectables to international pharmaceutical markets across Africa, Asia, CIS, and Middle East regions. As a reliable global supplier of bisphosphonate injections, the company supports hospitals, distributors, and tender-based procurement worldwide.

Zoledronic Acid for Injection is indicated for:

  • Bone metastases associated with cancer
  • Hypercalcemia of malignancy
  • Osteoporosis (postmenopausal and other forms)
  • Paget’s disease of bone
  • Prevention of skeletal-related events (SREs) in oncology patients
  • Provides long-lasting inhibition of bone resorption
  • Supports oncology supportive care in global treatment protocols
  • Suitable for single-dose IV infusion in hospital settings
  • Enables bulk supply for international tenders and hospital procurement
  • Ideal for global distribution in oncology and bone health markets

whatsapp-app